|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsim S, O'Dowd CA, Milroy R and Davidson
S: Staging of non-small cell lung cancer (NSCLC): A review. Respir
Med. 104:1767–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedman JM, Liang G, Liu CC, Wolff EM,
Tsai YC, Ye W, Zhou X and Jones PA: The putative tumor suppressor
microRNA-101 modulates the cancer epigenome by repressing the
polycomb group protein EZH2. Cancer Res. 69:2623–2629. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y
and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular
carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer
Res. 69:1135–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Varambally S, Cao Q, Mani RS, Shankar S,
Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, et al:
Genomic loss of microRNA-101 leads to overexpression of histone
methyltransferase EZH2 in cancer. Science. 322:1695–1699. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT,
Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric
cancer and involved in cell migration and invasion. Eur J Cancer.
46:2295–2303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JG, Guo JF, Liu DL, Liu Q and Wang
JJ: MicroRNA-101 exerts tumor-suppressive functions in non-small
cell lung cancer through directly targeting enhancer of zeste
homolog 2. J Thorac Oncol. 6:671–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thu KL, Chari R, Lockwood WW, Lam S and
Lam WL: miR-101 DNA copy loss is a prominent subtype specific event
in lung cancer. J Thorac Oncol. 6:1594–1598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guttman M, Russell P, Ingolia NT, Weissman
JS and Lander ES: Ribosome profiling provides evidence that large
noncoding RNAs do not encode proteins. Cell. 154:240–251. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bánfai B, Jia H, Khatun J, Wood E, Risk B,
Gundling WE Jr, Kundaje A, Gunawardena HP, Yu Y, Xie L, et al: Long
noncoding RNAs are rarely translated in two human cell lines.
Genome Res. 22:1646–1657. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Franco-Zorrilla JM, Valli A, Todesco M,
Mateos I, Puga MI, Rubio-Somoza I, Leyva A, Weigel D, García JA and
Paz-Ares J: Target mimicry provides a new mechanism for regulation
of microRNA activity. Nat Genet. 39:1033–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cazalla D, Yario T and Steitz JA:
Down-regulation of a host microRNA by a Herpesvirus saimiri
noncoding RNA. Science. 328:1563–1566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu Z, Du S, Yin K, Ai S, Yu M, Liu Y,
Shen Y, Liu M, Jiao R, Chen X and Guan W: Knockdown long noncoding
RNA nuclear paraspeckle assembly transcript 1 suppresses colorectal
cancer through modulating miR-193a-3p/KRAS. Cancer Med. 8:261–275.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Li Y, Wang B, Ma Y and Chen P:
LncRNA-PCAT-1 promotes non-small cell lung cancer progression by
regulating miR-149-5p/LRIG2 axis. J Cell Biochem. Dec 19–2018.(Epub
ahead of print) Doi: 10.1002/jcb.28046.
|
|
19
|
Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C,
Zhou Q, Chen X, Li Y, Lim Z, et al: Long non-coding RNA ATB
promotes malignancy of esophageal squamous cell carcinoma by
regulating miR-200b/Kindlin-2 axis. Cell Death Dis. 8:e28882017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu T, Wang Y, Chen D, Liu J and Jiao W:
Potential clinical application of lncRNAs in non-small cell lung
cancer. Onco Targets Ther. 11:8045–8052. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang H, Yu T, Han Y, Jiang H, Wang C, You
T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes EMT
and invasion-metastasis in serous ovarian cancer by competitively
binding miR-101-3p to regulate ZEB1 expression. Mol Cancer.
17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho HM, Jeon HS, Lee SY, Jeong KJ, Park
SY, Lee HY, Lee JU, Kim JH, Kwon SJ, Choi E, et al: microRNA-101
inhibits lung cancer invasion through the regulation of enhancer of
zeste homolog 2. Exp Ther Med. 2:963–967. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hou Y, Li L, Ju Y, Lu Y, Chang L and Xiang
X: MiR-101-3p regulates the viability of lung squamous carcinoma
cells via targeting EZH2. J Cell Biochem. 118:3142–3149. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan F, Shen N, Pang J, Xie D, Deng B,
Molina JR, Yang P and Liu S: Restoration of miR-101 suppresses lung
tumorigenesis through inhibition of DNMT3a-dependent DNA
methylation. Cell Death Dis. 5:e14132014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wan X, Kong Z, Chu K, Yi C, Hu J, Qin R,
Zhao C, Fu F, Wu H, Li Y and Huang Y: Co-expression analysis
revealed PTCH1-3′UTR promoted cell migration and invasion by
activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer:
Implicating the novel function of PTCH1. Oncotarget. 9:4798–4813.
2017.PubMed/NCBI
|
|
27
|
Wang H, Wang L, Zhang G, Lu C, Chu H, Yang
R and Zhao G: MALAT1/miR-101-3p/MCL1 axis mediates cisplatin
resistance in lung cancer. Oncotarget. 9:7501–7512. 2017.PubMed/NCBI
|
|
28
|
Lv P, Zhang P, Li X and Chen Y: Micro
ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion
of lung cancer by regulating cyclooxygenase-2. Thorac Cancer.
6:778–784. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Yao J, Sun H, He K, Tong D, Song T
and Huang C: MicroRNA-101 suppresses progression of lung cancer
through the PTEN/AKT signaling pathway by targeting DNA
methyltransferase 3A. Oncol Lett. 13:329–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han L, Chen W, Xia Y, Song Y, Zhao Z,
Cheng H and Jiang T: MiR-101 inhibits the proliferation and
metastasis of lung cancer by targeting zinc finger E-box binding
homeobox 1. Am J Transl Res. 10:1172–1183. 2018.PubMed/NCBI
|
